A large-scale analysis has revealed few biological and prognostic differences between HER2-low and HER2-negative breast cancer, and they should not be treated differently, say clinicians.
Medscape Medical News
HER2-Low Breast Cancer Is NOT a Separate Clinical Entity: Study
